Clinical trial

Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure

NCT03871699

Study summary

ClinicalTrials.gov

Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Ferric carboxymaltose Normalized identity: ferric carboxymaltose View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-08-30

PhasePHASE4

Conditions

Cardiac Failureverified · MONDO: heart failure

Systolic Heart Failureverified · MONDO: systolic heart failure

Heart Failure, Systoliccandidate · MONDO: systolic heart failure

Interventions

Ferric carboxymaltoseDRUG · verified · RxNorm: ferric carboxymaltose

Sponsors & collaborators

Hospital Moinhos de Ventolead sponsor

Takedacollaborator

Mapped research locations

Porto AlegreRio Grande do Sul, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03871699 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.